Radian Group heads into its August 5 earnings release carrying the most consequential insider-buying signal it has seen in years.
The standout is CEO Michael Weinbach, who purchased 170,000 shares across two consecutive days in early June, spending roughly $5.77 million at prices around $33.90–$34.04. That aggressive open-market buying — at a meaningful discount to today's $39.29 — dominates the 90-day insider flow picture, which nets to approximately 252,000 shares bought and $8.8 million deployed. The General Counsel sold $780,000 of stock in July, and a handful of directors trimmed small positions in May and June, but those moves are dwarfed by the CEO's conviction bet. The net flow is unambiguously bullish at the insider level.
The analyst community has moved in the same direction, though with less drama. Coverage has broadly been raising targets since early spring. Keefe Bruyette lifted its target to $46 in late June, maintaining Outperform. RBC initiated at Outperform with a $47 target in May. Bank of America upgraded the stock all the way from Underperform to Buy in late April, lifting its target to $43. The consensus sits at Hold with a $45 mean target — roughly 14% above the current price — though that single Hold rating reflects a thin coverage base rather than a bearish tilt in the analyst community. Barclays remains the cautious voice, holding at Equal-Weight with a $39 target that barely clears the current price. The bull case centers on a planned $200 million buyback authorization, double-digit return-on-equity guidance, and rising forward premium estimates. Bears point to a modest erosion in PMIERs excess capital — now at $2.09 billion versus $2.15 billion at year-end — and the prospect of declining reserve releases as credit conditions normalize.
Positioning ahead of the print tells a quiet, unencumbered story. Short interest runs at just 4.3% of the float, up roughly 12% over the past month but still modest in absolute terms. Borrowing the stock is essentially frictionless — availability runs at over 5,700% of short interest, meaning shares to lend dwarf the current short position by a factor of nearly 60. Cost to borrow is 0.37%, down about 7% on the week and 12% over the past month, confirming there is no meaningful squeeze pressure. Options positioning is equally relaxed: the put/call ratio at 0.22 is almost exactly in line with its 20-day average, with a z-score near zero. Radian has outperformed peers ESNT and MTG on the week, with NMIH the lone peer showing stronger momentum at +3.6% over five days. There is no sign of defensive hedging or elevated short interest in the run-up.
The earnings report is therefore less a positioning event than a credibility test for Weinbach's June conviction trade — the print will reveal whether the operating fundamentals, particularly new insurance written volumes and credit reserve trends, justify both the CEO's personal bet and the Street's recently upgraded targets.
See the live data behind this article on ORTEX.
Open RDN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
